Latest Insider Transactions at Vincerx Pharma, Inc. (VINC)
This section provides a real-time view of insider transactions for Vincerx Pharma, Inc. (VINC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vincerx Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vincerx Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2023
|
Alexander A. Seelenberger Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,500
+25.75%
|
$0
$0.95 P/Share
|
|
Aug 10
2023
|
Raquel E. Izumi |
BUY
Open market or private purchase
|
Indirect |
3,440
+3.88%
|
$0
$0.93 P/Share
|
|
Aug 10
2023
|
Tom C Thomas |
BUY
Open market or private purchase
|
Direct |
5,000
+2.22%
|
$0
$0.95 P/Share
|
|
Aug 10
2023
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
5,400
+5.32%
|
$0
$0.96 P/Share
|
|
Aug 09
2023
|
Raquel E. Izumi |
BUY
Open market or private purchase
|
Indirect |
13,036
+13.75%
|
$0
$0.9 P/Share
|
|
Aug 09
2023
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
16,900
+15.71%
|
$0
$0.95 P/Share
|
|
Dec 14
2022
|
Tom C Thomas |
BUY
Open market or private purchase
|
Indirect |
7,000
+41.18%
|
$0
$0.83 P/Share
|
|
Dec 14
2022
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
35,280
+32.36%
|
$0
$0.87 P/Share
|
|
Dec 14
2022
|
Raquel E. Izumi |
BUY
Open market or private purchase
|
Indirect |
28,738
+29.48%
|
$0
$0.88 P/Share
|
|
Aug 25
2022
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
11,600
+22.48%
|
$11,600
$1.65 P/Share
|
|
Aug 24
2022
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
18,400
+39.32%
|
$18,400
$1.65 P/Share
|
|
Jun 27
2022
|
Raquel E. Izumi |
BUY
Open market or private purchase
|
Indirect |
40,000
+50.0%
|
$40,000
$1.41 P/Share
|
|
Jun 23
2022
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
24,200
+38.61%
|
$24,200
$1.41 P/Share
|
|
Jun 09
2022
|
Laura I. Bushnell |
BUY
Open market or private purchase
|
Direct |
15,000
+43.86%
|
$15,000
$1.91 P/Share
|
|
Dec 23
2021
|
Sooin Hwang Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.76%
|
$30,000
$10.0 P/Share
|
|
Dec 22
2021
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
6,450
+31.11%
|
$64,500
$10.02 P/Share
|
|
Dec 22
2021
|
Alexander A. Seelenberger Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,417
+16.21%
|
$24,170
$10.34 P/Share
|
|
Dec 22
2021
|
Laura I. Bushnell |
BUY
Open market or private purchase
|
Direct |
2,402
+36.37%
|
$24,020
$10.48 P/Share
|
|
Dec 22
2021
|
Tom C Thomas |
BUY
Open market or private purchase
|
Indirect |
1,000
+25.0%
|
$10,000
$10.23 P/Share
|
|
Aug 04
2021
|
Raquel E. Izumi |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$11,000
$11.96 P/Share
|
|
Jun 30
2021
|
Sooin Hwang Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.13%
|
$6,000
$12.66 P/Share
|
|
Jun 30
2021
|
Laura I. Bushnell |
BUY
Open market or private purchase
|
Direct |
1,800
+50.0%
|
$21,600
$12.94 P/Share
|
|
Jun 30
2021
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
3,600
+26.47%
|
$43,200
$12.66 P/Share
|
|
Jun 29
2021
|
Andrew I Mc Donald Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$240,000
$12.38 P/Share
|
|
Jun 29
2021
|
John H. Lee |
BUY
Open market or private purchase
|
Direct |
799
+50.0%
|
$9,588
$12.71 P/Share
|
|
Jun 29
2021
|
Tom C Thomas |
BUY
Open market or private purchase
|
Indirect |
2,000
+50.0%
|
$24,000
$12.58 P/Share
|
|
Jun 29
2021
|
Christopher P. Lowe Director |
BUY
Open market or private purchase
|
Direct |
6,400
+50.0%
|
$76,800
$12.59 P/Share
|
|
Jun 29
2021
|
Alexander A. Seelenberger Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,950
+50.0%
|
$95,400
$12.61 P/Share
|
|
Jun 29
2021
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
7,830
+50.0%
|
$93,960
$12.77 P/Share
|
|
Jan 28
2021
|
Andrew I Mc Donald Director |
BUY
Other acquisition or disposition
|
Indirect |
808,471
+50.0%
|
-
|
|
Jan 28
2021
|
Andrew I Mc Donald Director |
SELL
Other acquisition or disposition
|
Indirect |
1,616,942
-100.0%
|
-
|
|
Dec 23
2020
|
John C. Byrd > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
1,618,199
+50.0%
|
-
|
|
Dec 23
2020
|
Brian Druker |
BUY
Grant, award, or other acquisition
|
Direct |
54,806
+50.0%
|
-
|
|
Dec 23
2020
|
Raquel E. Izumi |
BUY
Grant, award, or other acquisition
|
Direct |
1,618,199
+50.0%
|
-
|
|
Dec 23
2020
|
Ahmed Md Hamdy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,618,199
+50.0%
|
-
|